Put Options Transactions Made in Q1 2023 in Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX) during Q1 2023. The information is specifically focused on institutions that hold put options of Celldex Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
PUT |
110KNew |
$3.83M - $5.22M
|
110K
$2.9M
|
|
|
May 15, 2023
Q1 2023
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
PUT |
22.5KNew |
$783K - $1.07M
|
22.5K
$594K
|
|
|
May 01, 2023
Q1 2023
|
Cutler Group LP
|
SELL
|
PUT |
-5.1K- 70.83% |
$177K - $242K
|
2.1K
$55.4K
|
|
|
May 15, 2023
Q1 2023
|
Creative Planning
Overland Park, KS |
SELL
|
PUT |
-10.6K- 54.08% |
$369K - $503K
|
9K
$238K
|
|
|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
PUT |
-12.3K- 48.81% |
$428K - $583K
|
12.9K
$341K
|
|
|
May 16, 2023
Q1 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
PUT |
-83.1K- 55.85% |
$2.89M - $3.94M
|
65.7K
$1.73M
|